Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 85

1.

Formosanin-C, an immunomodulator with antitumor activity.

Wu RT, Chiang HC, Fu WC, Chien KY, Chung YM, Horng LY.

Int J Immunopharmacol. 1990;12(7):777-86.

PMID:
2292459
2.
3.

Modulation of experimental autoimmune uveitis with formosanin-C in guinea pigs.

Wu RT, Lin WJ, Chiang HC, Horng LY, Chung YM.

J Ocul Pharmacol. 1990 Winter;6(4):301-11.

PMID:
2097314
4.

Immunomodulators from Paris formosana Hayata.

Chiang HC, Wang JJ, Wu RT.

Anticancer Res. 1992 May-Jun;12(3):949-57.

PMID:
1622153
5.

Formosanin C-induced apoptosis requires activation of caspase-2 and change of mitochondrial membrane potential.

Lee JC, Su CL, Chen LL, Won SJ.

Cancer Sci. 2009 Mar;100(3):503-13. doi: 10.1111/j.1349-7006.2008.01057.x. Epub 2008 Dec 16.

6.

Enhancement of natural killer cell-mediated cytotoxicity by coexpression of GM-CSF/B70 in hepatoma.

Kim KY, Kang MA, Nam MJ.

Cancer Lett. 2001 May 10;166(1):33-40.

PMID:
11295284
7.

Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells.

Yoon TJ, Yoo YC, Kang TB, Song SK, Lee KB, Her E, Song KS, Kim JB.

Arch Pharm Res. 2003 Oct;26(10):861-7.

PMID:
14609136
8.

Immunomodulatory activity of protein-bound polysaccharide extracted from Chelidonium majus.

Song JY, Yang HO, Pyo SN, Jung IS, Yi SY, Yun YS.

Arch Pharm Res. 2002 Apr;25(2):158-64.

PMID:
12009029
9.

Anti-metastatic activity induced by the in vivo activation of purified protein derivative (PPD)-recognizing Th1 type CD4+ T cells.

Shinomiya Y, Harada M, Kurosawa S, Okamoto T, Terao H, Matsuzaki G, Shirakusa T, Nomoto K.

Immunobiology. 1995 Aug;193(5):439-55.

PMID:
8522359
10.

Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.

Tsuchiya Y, Igarashi M, Suzuki R, Kumagai K.

J Immunol. 1988 Jul 15;141(2):699-708.

PMID:
2968407
11.
12.

Balanitin-6 and -7: diosgenyl saponins isolated from Balanites aegyptiaca Del. display significant anti-tumor activity in vitro and in vivo.

Gnoula C, Mégalizzi V, De Nève N, Sauvage S, Ribaucour F, Guissou P, Duez P, Dubois J, Ingrassia L, Lefranc F, Kiss R, Mijatovic T.

Int J Oncol. 2008 Jan;32(1):5-15.

PMID:
18097538
13.
14.

Hematopoietic and lymphopoietic responses in human granulocyte-macrophage colony-stimulating factor (GM-CSF) receptor transgenic mice injected with human GM-CSF.

Nishijima I, Nakahata T, Watanabe S, Tsuji K, Tanaka I, Hirabayashi Y, Inoue T, Arai K.

Blood. 1997 Aug 1;90(3):1031-8.

15.
16.
17.

Effect of the immunomodulator AS101 on chemotherapy-induced multilineage myelosuppression, thrombocytopenia, and anemia in mice.

Kalechman Y, Rushkin G, Nerubay J, Albeck M, Sredni B.

Exp Hematol. 1995 Dec;23(13):1358-66.

PMID:
7498364
19.
20.

Combined therapy with interleukin 2 and indomethacin in mice inoculated with MH134 hepatoma.

Tanaka N, Okamoto Y, Gotoh K, Hizuta A, Yunoki S, Orita K.

Acta Med Okayama. 1995 Oct;49(5):241-5.

PMID:
8585394

Supplemental Content

Support Center